recombinant Lysostaphin - EC 3.4.24.75
Order number: S5201.0001
Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!CAS-Nr: 9011-93-2
Ready to ship today,
Delivery time 1-3 workdays
*Prices plus VAT plus shipping costs
Lysostaphin, an endopeptidase specific for the cell wall peptidoglycan of staphylococci, is an extremely potent anti-staphylococcal agent. Lysostaphin is used as a research and diagnostic tool. Because it lyses staphylococci efficiently, it is widely used when preparing staphylococcal DNA or other cellular components for genetic and biochemical studies and for the preparation of protoplasts for transformation. Preparation and analysis of bacterial DNA has become a powerful tool used by clinical and other microbiologists in epidemiological studies aimed at tracing sources of infection or bacterial contamination.
Lysis of peptidoglycan cell wall of staphylococci! potent anti-staphylococcal agent
Technical Data:
Specifications:
Purity: >95% as determined by RP-HPLC
Specific activity: >1000 units/mg (determined by the decrease in turbidity of a suspension of heat-killed Staphylococcus aureus at pH8.0, 30°C)
MW = 26,921 Da (246 amino acids)
application:
- preparation of staphylococcal DNA - preparation of other staphylococcal cellular components - for preparation of protoplasts for transformationSource
Escherichia Coli.Sicherheits Hinweise / Safety
Klassifizierungen / Classification
CAS-Nr: 9011-93-2eclass-Nr: 32-16-04-10
Dokumente - Protokolle - Downloads
Here you will find information and further literature on recombinant Lysostaphin - EC 3.4.24.75. For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: info@genaxxon.com or phone: +49 731 3608 123.
Referenzen..
Hier finden Sie Artikel und Literaturzitate, in denen die Autoren auf die hohe Qualität dieses Genaxxonprodukts vertrauen.
Listed below are articles and references, in which the authors trust in the high quality of this Genaxxon product.
Dennis Nurjadi, Sébastien Boutin, Alexander Dalpke, Klaus Heeg, Philipp Zanger
Genome Announc. 2018 May; 6(19): e00411-18. Published online 2018 May 10. doi: 10.1128/genomeA.00411-18
PMCID: PMC5946038
